Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Entourage-Psilocybin-GanzpilzZenodo (CERN European Organization for Nuclear Research) · 2026-07-07Entourage-Psilocybin-GanzpilzZenodo (CERN European Organization for Nuclear Research) · 2026-07-07Prohedonic Effects of Psilocybin (COMP360) in a Touchscreen-Based Rodent Probabilistic Reward Task (Abstract ID: 227883)Journal of Pharmacology and Experimental Therapeutics · 2026-04-30Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial - CORRIGENDUMBJPsych Open · 2026-04-30Does Psychological Flexibility Correlate with Mystical Experiences: A Machine Learning Approach Including State of Surrender, Near-Death Experiences, and Psilocybin ConsumptionBehavioral Sciences · 2026-04-29Distinct Modulatory Effects on Affective Biases by Different Serotonergic Psychedelics and MDMA in Male Rats: Possible Implications for Antidepressant EffectsbioRxiv · 2026-04-21Inhibition of cortico-amygdala projections underlies affective bias modification by psilocybinbioRxiv · 2026-03-03Efficacy and risks of psychedelics in the treatment of posttraumatic stress disorder: A systematic reviewAmerican Journal of Health-System Pharmacy · 2026-03-03Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trialBJPsych Open · 2026-02-15Challenges with clinical trial participants in studies with classical psychedelics: A position statement from the National Network of Depression Centers’ task group on psychedelics and related compoundsJournal of Psychopharmacology · 2026-02-04Psilocybin wirkt bei therapieresistenter DepressionDNP - Die Neurologie & Psychiatrie · 2026-01-31Psilocybin rapidly, but not immediately, reverses reward learning deficits in a durable manner in an inflammatory rat model of depressive symptomsbioRxiv · 2026-01-14Toxicology and Pharmacological Interactions of Classic Psychedelics.Unknown journal · 2025-12-31Assessing The Readiness of Psychiatrists in Louisiana to Incorporate Psilocybin into Clinical Practice-Lessons Learned from a State Underrepresented in Clinical Psychedelic ResearchPsychedelic Medicine · 2025-12-18Metastability of resting-state bold fMRI as a reliable biomarker of individual brain dynamics: An interrogation of within-subject variability as a function of total acquisition timeNetwork Neuroscience · 2025-12-08Correction: Short- and long-term modulation of rat prefrontal cortical activity following single doses of psilocybin.Unknown journal · 2025-11-30Sex-specific role of the 5-HT2A receptor in psilocybin-induced extinction of opioid rewardNature Communications · 2025-11-19Ketamine and psilocybin for athletes: A therapeutic breakthrough or a slippery slope?Performance Enhancement & Health · 2025-10-31Differential effects of psilocybin and lisuride on serotonin and dopamine neuronal activity and behaviorProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2025-09-30Concomitant use of antidepressants and classic psychedelics: A scoping review.Unknown journal · 2025-09-11Short- and long-term modulation of rat prefrontal cortical activity following single doses of psilocybinMolecular Psychiatry · 2025-08-25In Vitro Psilocybin Synthesis by Co-Immobilized EnzymesChemistry - A European Journal · 2025-04-08Sporadic use of classic psychedelics and neuropsychological performance: A cross-sectional analysisProgress in Neuro-Psychopharmacology and Biological Psychiatry · 2025-03-31Interview with Allen Kalpin and Reiko Ikemoto-Joseph: psychedelics and ISTDPJournal of Contemporary ISTDP · 2025-03-13Suicide of a patient shortly after psilocybin-assisted psychedelic therapy: A case reportPsychiatry Research · 2025-01-28Neuropsychological profiles of patients suffering from hallucinogen persisting perception disorder (HPPD): A comparative analysis with psychedelic-using and non-using controlsScientific Reports · 2024-12-30The role of the psychedelic experience in psilocybin treatment for treatment-resistant depressionJournal of Affective Disorders · 2024-12-17Short- and long-term reconfiguration of rat prefrontal cortical networks following single doses of psilocybinbioRxiv · 2024-12-12Psilocybin Therapy for Clinicians With Symptoms of Depression From Frontline Care During the COVID-19 PandemicJAMA Network Open · 2024-12-04The Psychedelic Renaissance: A Catholic PerspectiveThe Linacre Quarterly · 2024-09-14Acute Adverse Effects of Therapeutic Doses of Psilocybin: A Systematic Review and Meta-Analysis.Unknown journal · 2024-03-31National and regional trends in seizures of shrooms (psilocybin) in the United States, 2017-2022Drug and Alcohol Dependence · 2024-02-05Psilocybin gegen DepressionenCME · 2024-01-31Psilocybin vs Escitalopram for depression: 6-month follow-upNeuroscience Applied · 2023-12-31Commentary: Evidence-Informed Recommendation to Achieve Approximate Parity in the Allowed Number of Doses for Common Psychedelics.Journal of psychoactive drugs · 2023-12-31Psilocybin kann offenbar Depressionen lindernMMW - Fortschritte der Medizin · 2023-09-26Psilocybin analog 4-OH-DiPT enhances fear extinction and GABAergic inhibition of principal neurons in the basolateral amygdalaNeuropsychopharmacology · 2023-09-25Comparison of fragrance and flavor components in non-psilocybin and psilocybin mushrooms using vacuum-assisted headspace high-capacity solid-phase microextraction and gas chromatography-mass spectrometryAdvances in Sample Preparation · 2023-09-01Medical Students' Attitudes and Beliefs Toward Psilocybin: Does Terminology and Personal Experience with Psychedelics Matter?Psychedelic Medicine · 2023-08-17Psychotherapists' openness to engage their patients in Psilocybin-Assisted Therapy for mental health treatmentJournal of Affective Disorders · 2022-12-15Comparison of psychedelic and near-death or other non-ordinary experiences in changing attitudes about death and dying.PLoS ONE · 2022-08-23Psilocybin use patterns and perception of risk among a cohort of Black individuals with Opioid Use Disorder.Journal of Psychedelic Studies · 2022-08-04Magic Mushrooms - an exploratory look at how mental health professionals feel and think about Psilocybin.Psychiatry Research · 2022-07-15Serotonin toxicity of serotonergic psychedelics.Psychopharmacology · 2022-05-31Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review.Unknown journal · 2022-03-06Psilocin acutely alters sleep-wake architecture and cortical brain activity in laboratory mice.Translational Psychiatry · 2022-02-22Psilocybin Conspectus: Status, Production Methods, and Considerations.International journal of medicinal mushrooms · 2021-12-31Psilocin acutely disrupts sleep and affects local but not global sleep homeostasis in laboratory micebioRxiv · 2021-02-16Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD.Journal of Psychopharmacology · 2021-01-08Examining the Potential Synergistic Effects Between Mindfulness Training and Psychedelic-Assisted Therapy.Frontiers in psychiatry · 2020-12-31Microdosing psychedelics: Subjective benefits and challenges, substance testing behavior, and the relevance of intentionJournal of Psychopharmacology · 2020-10-07P300-mediated modulations in self-other processing under psychedelic psilocybin are related to connectedness and changed meaning: A window into the self-other overlapHuman Brain Mapping · 2020-08-20Microdosing psychedelics: Demographics, practices, and psychiatric comorbiditiesJournal of Psychopharmacology · 2020-02-27Psilocybin-assisted therapy for depression: How do we advance the field?Australian & New Zealand Journal of Psychiatry · 2019-11-21Psychedelic microdosing benefits and challenges: an empirical codebookHarm Reduction Journal · 2019-07-08Psychedelics as anti-inflammatory agents.International Review of Psychiatry · 2018-08-12High dose psilocybin is associated with positive subjective effects in healthy volunteers.Journal of Psychopharmacology · 2018-06-26Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts.Journal of Psychopharmacology · 2018-06-24Cancer at the Dinner Table: Experiences of Psilocybin-Assisted Psychotherapy for the Treatment of Cancer-Related Psychological DistressWestern CEDAR (Western Washington University) · 2017-12-31Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults.Clinical Pharmacokinetics · 2017-11-30LSD Increases Primary Process Thinking via Serotonin 2A Receptor Activation.Frontiers in Pharmacology · 2017-11-07Effect of Psilocybin on Empathy and Moral Decision-Making.The International Journal of Neuropsychopharmacology · 2017-08-31Cancer at the Dinner Table: Experiences of Psilocybin-Assisted Psychotherapy for the Treatment of Cancer-Related DistressJournal of Humanistic Psychology · 2017-06-13Psilocybin-Assisted Therapy: A Review of a Novel Treatment for Psychiatric Disorders.Unknown journal · 2017-05-07Patient Experiences of Psilocybin-Assisted Psychotherapy: An Interpretative Phenomenological AnalysisJournal of Humanistic Psychology · 2017-04-27Anti-inflammatory effects of serotonin 5-HT2A receptor activation in ovalbumin-induced allergic asthma modelsThe FASEB Journal · 2017-03-31"Flipping the Switch": Connective Effect of Psilocybin Mushrooms Help Hospice Patients Enjoy End of LifeUnknown journal · 2016-12-31Effects of serotonin 2A/1A receptor stimulation on social exclusion processing.Proceedings of the National Academy of Sciences · 2016-04-17Modulatory effect of the 5-HT1A agonist buspirone and the mixed non-hallucinogenic 5-HT1A/2A agonist ergotamine on psilocybin-induced psychedelic experience.European Neuropsychopharmacology · 2016-01-21P.1.i.005 The 5-HT2A/1A agonist psilocybin reduces social pain and enhances empathy in healthy volunteersEuropean Neuropsychopharmacology · 2015-08-31Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations.Psychopharmacology · 2015-07-31The Effect of 5-HT2A/1a Agonist Treatment On Social Cognition, Empathy, and Social Decision-makingEuropean Psychiatry · 2015-02-28Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers.Biological Psychiatry · 2014-04-25Spatiotemporal brain dynamics of emotional face processing modulations induced by the serotonin 1A/2A receptor agonist psilocybin.Cerebral Cortex · 2013-07-15What geometric visual hallucinations tell us about the visual cortex.Unknown journal · 2002-02-28Comparative effects of the administration of taraxein, d-LSD, mescaline, and psilocybin to human volunteersComprehensive Psychiatry · 1960-11-30